Seelos Therapeutics Prices $1.1M Registered Direct Offering And Concurrent Private Placement At $2.46/Share
Portfolio Pulse from Benzinga Newsdesk
Seelos Therapeutics, Inc. (NASDAQ:SEEL) has announced a $1.1 million registered direct offering and concurrent private placement at $2.46 per share. The offering includes 380,968 shares of common stock and pre-funded warrants to purchase up to 81,239 shares of common stock.
May 17, 2024 | 4:41 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Seelos Therapeutics has announced a $1.1 million registered direct offering and concurrent private placement at $2.46 per share. This move is likely to impact the stock price in the short term.
The announcement of a registered direct offering and private placement typically leads to a short-term decrease in stock price due to dilution concerns. The offering price of $2.46 per share may also set a near-term price ceiling.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100